Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Giorgio L Colombo, Sergio Di Matteo & Franco Maggiolo. (2013) Antiretroviral therapy in HIV-infected patients: a proposal to assess the economic value of the single-tablet regimen. ClinicoEconomics and Outcomes Research 5, pages 59-68.
Read now
Read now
V. Giacomet, V. Fabiano, R. Lo Muto, M.A. Caiazzo, A. Curto, O. Rampon, G.V. Zuccotti & L. Garattini. (2013) Resource utilization and direct costs of pediatric HIV in Italy. AIDS Care 25:11, pages 1392-1398.
Read now
Read now
Giuliano Rizzardini, Umberto Restelli, Paolo Bonfanti, Emanuele Porazzi, Elena Ricci, Emanuela Foglia, Laura Carenzi & Davide Croce. (2012) Cost of human immunodeficiency virus infection in Italy, 2007–2009: effective and expensive, are the new drugs worthwhile?. ClinicoEconomics and Outcomes Research 4, pages 245-252.
Read now
Read now
Giorgio L Colombo, Vincenzo Colangeli, Antonio Di Biagio, Sergio Di Matteo, Claudio Viscoli & Pierluigi Viale. (2011) Cost-effectiveness analysis of initial HIV treatment under Italian guidelines. ClinicoEconomics and Outcomes Research 3, pages 197-205.
Read now
Read now
G.A.A. Hubben, D. Bishai, P. Pechlivanoglou, A.M. Cattelan, R. Grisetti, C. Facchin, F.A. Compostella, J.M. Bos, M.J. Postma & A. Tramarin. (2008) The societal burden of HIV/AIDS in Northern Italy: An analysis of costs and quality of life. AIDS Care 20:4, pages 449-455.
Read now
Read now
A. G. Purdum, K. A. Johnson & D. R. Globe. (2004) Comparing total health care costs and treatment patterns of HIV patients in a managed care setting. AIDS Care 16:6, pages 767-780.
Read now
Read now
A. Tramarin, M. J. Postma, S. Gerzeli, S. Campostrini & F. Staracefor the Palladio Study Group. (2004) The clinical and economic efficacy of HAART: a shift from inpatient medical to outpatient pharmaceutical care for HIV/AIDS patients in Northeastern Italy. AIDS Care 16:2, pages 213-218.
Read now
Read now
Articles from other publishers (23)
Mazin Barry, Leen Ghonem, Nourah Albeeshi, Maha Alrabiah, Aynaa Alsharidi & Hussain Abdulrahman Al-Omar. (2022) Resource Utilization and Caring Cost of People Living with Human Immunodeficiency Virus (PLHIV) in Saudi Arabia: A Tertiary Care University Hospital Experience. Healthcare 10:1, pages 118.
Crossref
Crossref
Massomeh Hajilee, Mahsa Oroojeni Mohammad Javad & Linda A. Hayes. (2020) On the link between HIV prevalence and health expenditure: an asymmetric analysis. Journal of Economic Studies 47:3, pages 509-526.
Crossref
Crossref
Graeme Meintjes, Andrew D. Kerkhoff, Rosie Burton, Charlotte Schutz, Andrew Boulle, Gavin Van Wyk, Liz Blumenthal, Mark P. Nicol & Stephen D. Lawn. (2015) HIV-Related Medical Admissions to a South African District Hospital Remain Frequent Despite Effective Antiretroviral Therapy Scale-Up. Medicine 94:50, pages e2269.
Crossref
Crossref
Katelijne van de Vooren, Alessandro Curto & Livio Garattini. (2014) Pricing of forthcoming therapies for hepatitis C in Europe: beyond cost-effectiveness?. The European Journal of Health Economics 16:4, pages 341-345.
Crossref
Crossref
Aline Brennan, Deirdre Morley, Aisling C. O’Leary, Colm J. Bergin & Mary Horgan. (2014) Determinants of HIV Outpatient Service Utilization: A Systematic Review. AIDS and Behavior 19:1, pages 104-119.
Crossref
Crossref
Gesine Meyer-Rath, Alana T. Brennan, Matthew P. Fox, Tebogo Modisenyane, Nkeko Tshabangu, Lerato Mohapi, Sydney Rosen & Neil Martinson. (2013) Rates and Cost of Hospitalization Before and After Initiation of Antiretroviral Therapy in Urban and Rural Settings in South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes 62:3, pages 322-328.
Crossref
Crossref
Flavia Mori Sarti, Marislei Nishijima, Antonio Carlos Coelho Campino & Denise Cavallini Cyrillo. (2012) A comparative analysis of outpatient costs in HIV treatment programs. Revista da Associação Médica Brasileira 58:5, pages 561-567.
Crossref
Crossref
Flavia Mori Sarti, Marislei Nishijima, Antonio Carlos Coelho Campino & Denise Cavallini Cyrillo. (2012) A comparative analysis of outpatient costs in HIV treatment programs. Revista da Associação Médica Brasileira (English Edition) 58:5, pages 561-567.
Crossref
Crossref
Flavia Mori Sarti, Marislei Nishijima, Antonio Carlos Coelho Campino & Denise Cavallini Cyrillo. (2012) A comparative analysis of outpatient costs in HIV treatment programs. Revista da Associação Médica Brasileira 58:5, pages 561-567.
Crossref
Crossref
Caroline E. Sloan, Karen Champenois, Philippe Choisy, Elena Losina, Rochelle P. Walensky, Bruce R. Schackman, Faiza Ajana, Hugues Melliez, A.D. Paltiel, Kenneth A. Freedberg & Yazdan Yazdanpanah. (2012) Newer drugs and earlier treatment. AIDS 26:1, pages 45-56.
Crossref
Crossref
Giuliano Rizzardini, Umberto Restelli, Paolo Bonfanti, Emanuele Porazzi, Elena Ricci, Luca Casartelli, Emanuela Foglia, Laura Carenzi, Paola Citterio, Giovanna Orlando, Carlo Maselli & Davide Croce. (2011) The Cost of HIV Disease in Northern Italy: The Payer's Perspective. JAIDS Journal of Acquired Immune Deficiency Syndromes 57:3, pages 211-217.
Crossref
Crossref
Karen Moeremans, Lindsay Hemmett, Jonas Hjelmgren, Gabriele Allegri & Erik Smets. (2012) Cost Effectiveness of Darunavir/Ritonavir 600/100mg bid in Treatment-Experienced, Lopinavir-Naive, Protease Inhibitor-Resistant, HIV-Infected Adults in Belgium, Italy, Sweden and the UK. PharmacoEconomics 28:S1, pages 147-167.
Crossref
Crossref
Karen Moeremans, Lieven Annemans, Mickael Löthgren, Gabriele Allegri, Veronique Wyffels, Lindsay Hemmet, Karin Caekelbergh & Erik Smets. (2012) Cost Effectiveness of Darunavir/Ritonavir 600/100mg bid in Protease Inhibitor-Experienced, HIV-1-Infected Adults in Belgium, Italy, Sweden and the UK. PharmacoEconomics 28:S1, pages 107-128.
Crossref
Crossref
Adrian Levy, Karissa Johnston, Lieven Annemans, Andrea Tramarin & Julio Montaner. (2012) The Impact of Disease Stage on Direct Medical Costs of HIV Management. PharmacoEconomics 28:S1, pages 35-47.
Crossref
Crossref
Juan Oliva-Moreno, Julio López-Bastida, Pedro Serrano-Aguilar & Lilisbeth Perestelo-Pérez. (2010) Determinants of health care costs of HIV-positive patients in the Canary Islands, Spain. The European Journal of Health Economics 11:4, pages 405-412.
Crossref
Crossref
Eduard J Beck, Guy Harling, Sofia Gerbase & Paul DeLay. (2010) The cost of treatment and care for people living with HIV infection: implications of published studies, 1999–2008. Current Opinion in HIV and AIDS 5:3, pages 215-224.
Crossref
Crossref
Julio Lopez-Bastida, Juan Oliva-Moreno, Lilisbeth Perestelo-Perez & Pedro Serrano-Aguilar. (2009) The economic costs and health-related quality of life of people with HIV/AIDS in the Canary Islands, Spain. BMC Health Services Research 9:1.
Crossref
Crossref
Adrian R Levy, Douglas James, Karissa M Johnston, Robert S Hogg, P Richard Harrigan, Brian P Harrigan, Boris Sobolev & Julio S Montaner. (2006) The direct costs of HIV/AIDS care. The Lancet Infectious Diseases 6:3, pages 171-177.
Crossref
Crossref
Monica Merito, Andrea Bonaccorsi, Fabio Pammolli, Massimo Riccaboni, Gianluca Baio, Claudio Arici, Antonella D’Arminio Monforte, Patrizio Pezzotti, Dario Corsini, Andrea Tramarin, Roberto Cauda, Vincenzo Colangeli & Giuseppe Pastore. (2005) Economic evaluation of HIV treatments: The I.CO.N.A. cohort study. Health Policy 74:3, pages 304-313.
Crossref
Crossref
Yves A Flori & Marc le Vaillant. (2004) Use and Cost of Antiretrovirals in France 1995???2000. PharmacoEconomics 22:16, pages 1061-1070.
Crossref
Crossref
Andrea Tramarin, Stefano Campostrini, Maarten J Postma, Guido Calleri, Keith Tolley, Nicoletta Parise & Fausto de Lalla. (2004) A Multicentre Study of Patient Survival, Disability, Quality of Life and Cost of Care. PharmacoEconomics 22:1, pages 43-53.
Crossref
Crossref
M. Stoll & R. E. Schmidt. (2003) Ökonomische Aspekte der ambulanten und stationären Behandlung HIV-Infizierter. Der Internist 44:6, pages 678-693.
Crossref
Crossref
C. Ruef. (2014) Cost of Infectious Diseases. Infection 30:2, pages 59-60.
Crossref
Crossref